Clinical trial • Not applicable • Immunology | Oncology
Clinical trial in Advanced solid tumour
Not applicable trial for Advanced solid tumour. 220 participants.
Overview
- Trial Therapeutic Area
- Immunology | Oncology
- Trial Disease
- Advanced solid tumour
- Trial Stage
- Not applicable
Key dates
- Initial CTIS Submission Date
- 19-09-2024
- First CTIS Authorization Date
- 27-01-2025
Trial design
Not applicable trial across 16 sites in Romania, France, Spain and others.
- Target Sample Size
- 220
Eligibility
Recruits 220 Vulnerable population not selected; no specific consent or assent handling described..
- Vulnerable Population
- Vulnerable population not selected; no specific consent or assent handling described.
Recruitment
- Planned Sample Size
- 220
- Recruitment Window Months
- 22
Geography
- Total Number Of Sites
- 16
- Total Number Of Participants
- 128
Romania
- Earliest CTIS Part Ii Submission Date
- 17-01-2025
- Latest Decision Or Authorization Date
- 03-02-2025
- Processing Time Days
- 17
- Number Of Sites
- 4
- Number Of Participants
- 32
Sites
- Site Name
- Centrul De Oncologie-Euroclinic S.R.L.
- Department Name
- Oncology
- Principal Investigator Name
- Constantin Volovăț
- Principal Investigator Email
- cvolovat@gmail.com
- Contact Person Name
- Constantin Volovăț
- Contact Person Email
- cvolovat@gmail.com
- Site Name
- Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti
- Department Name
- Oncology
- Principal Investigator Name
- Laurenția Nicoleta Galeș
- Principal Investigator Email
- laurentia.gales.ext@arensia-em.com
- Contact Person Name
- Laurenția Nicoleta Galeș
- Contact Person Email
- laurentia.gales.ext@arensia-em.com
- Site Name
- Centrul De Oncologie SF Nectarie S.R.L.
- Department Name
- Oncology
- Principal Investigator Name
- Michael Schenker
- Principal Investigator Email
- Mike_schenker@yahoo.com
- Contact Person Name
- Michael Schenker
- Contact Person Email
- Mike_schenker@yahoo.com
- Site Name
- Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca
- Department Name
- Oncology
- Principal Investigator Name
- Tudor Eliade Ciuleanu
- Principal Investigator Email
- tudor.ciuleanu.ext@arensia-em.com
- Contact Person Name
- Tudor Eliade Ciuleanu
- Contact Person Email
- tudor.ciuleanu.ext@arensia-em.com
France
- Earliest CTIS Part Ii Submission Date
- 13-01-2025
- Latest Decision Or Authorization Date
- 29-01-2025
- Processing Time Days
- 16
- Number Of Sites
- 4
- Number Of Participants
- 32
Sites
- Site Name
- Institut De Cancerologie De L Ouest
- Department Name
- Medical Oncology
- Principal Investigator Name
- Frédéric ROLLAND
- Principal Investigator Email
- frederic.rolland@ico.unicancer.fr
- Contact Person Name
- Frédéric ROLLAND
- Contact Person Email
- frederic.rolland@ico.unicancer.fr
- Site Name
- Centre Hospitalier Universitaire De Poitiers
- Department Name
- Medical Oncology
- Principal Investigator Name
- Sheik EMAMBUX
- Principal Investigator Email
- sheik.emambux@chu-poitiers.fr
- Contact Person Name
- Sheik EMAMBUX
- Contact Person Email
- sheik.emambux@chu-poitiers.fr
- Site Name
- Institut Gustave Roussy
- Department Name
- Early Drug Development and Genitourinary Oncology Group
- Principal Investigator Name
- Yohann LORIOT
- Principal Investigator Email
- yohann.loriot@gustaveroussy.fr
- Contact Person Name
- Yohann LORIOT
- Contact Person Email
- yohann.loriot@gustaveroussy.fr
- Site Name
- Institut Regional Du Cancer De Montpellier
- Department Name
- Medical Oncology
- Principal Investigator Name
- Diego TOSI
- Principal Investigator Email
- Diego.Tosi@icm.unicancer.fr
- Contact Person Name
- Diego TOSI
- Contact Person Email
- Diego.Tosi@icm.unicancer.fr
Spain
- Earliest CTIS Part Ii Submission Date
- 16-01-2025
- Latest Decision Or Authorization Date
- 27-01-2025
- Processing Time Days
- 11
- Number Of Sites
- 4
- Number Of Participants
- 32
Sites
- Site Name
- Hospital Universitari Vall D Hebron
- Department Name
- Oncology
- Principal Investigator Name
- Maria Julia Lostes Bardaji
- Principal Investigator Email
- jlostes@vhio.net
- Contact Person Name
- Maria Julia Lostes Bardaji
- Contact Person Email
- jlostes@vhio.net
- Site Name
- Hospital Universitario Fundacion Jimenez Diaz
- Department Name
- Oncology
- Principal Investigator Name
- Bernard Doger de Speville
- Principal Investigator Email
- Bernard.doger@startmadrid.com
- Contact Person Name
- Bernard Doger de Speville
- Contact Person Email
- Bernard.doger@startmadrid.com
- Site Name
- Hospital Universitario Y Politecnico La Fe
- Department Name
- Oncology
- Principal Investigator Name
- Guillermo Suay Montagud
- Principal Investigator Email
- guillermo_suay@iislafe.es
- Contact Person Name
- Guillermo Suay Montagud
- Contact Person Email
- guillermo_suay@iislafe.es
- Site Name
- Hospital Quironsalud Barcelona
- Department Name
- Oncology
- Principal Investigator Name
- Omar Saavedra
- Principal Investigator Email
- osaavedra@nextoncology.eu
- Contact Person Name
- Omar Saavedra
- Contact Person Email
- osaavedra@nextoncology.eu
Italy
- Earliest CTIS Part Ii Submission Date
- 15-01-2025
- Latest Decision Or Authorization Date
- 29-01-2025
- Processing Time Days
- 14
- Number Of Sites
- 4
- Number Of Participants
- 32
Sites
- Site Name
- Istituto Europeo Di Oncologia S.r.l.
- Department Name
- Oncology
- Principal Investigator Name
- Giuseppe Curigliano
- Principal Investigator Email
- giuseppe.curigliano@ieo.it
- Contact Person Name
- Giuseppe Curigliano
- Contact Person Email
- giuseppe.curigliano@ieo.it
- Site Name
- Careggi University Hospital
- Department Name
- Oncology
- Principal Investigator Name
- Lorenzo Antonuzzo
- Principal Investigator Email
- antonuzzol@aou-careggi.toscana.it
- Contact Person Name
- Lorenzo Antonuzzo
- Contact Person Email
- antonuzzol@aou-careggi.toscana.it
- Site Name
- Centro Ricerche Cliniche Di Verona S.r.l.
- Department Name
- Oncology
- Principal Investigator Name
- Andrea Zivi
- Principal Investigator Email
- andrea.zivi@aovr.veneto.it
- Contact Person Name
- Andrea Zivi
- Contact Person Email
- andrea.zivi@aovr.veneto.it
- Site Name
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Department Name
- Oncology
- Principal Investigator Name
- Gennaro Daniele
- Principal Investigator Email
- gennaro.daniele@policlinogemelli.it
- Contact Person Name
- Gennaro Daniele
- Contact Person Email
- gennaro.daniele@policlinogemelli.it
Sponsor
Primary sponsor
- Full Name
- Corbus Pharmaceuticals Inc.
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- United States
Related trials
Other published trials that may interest you.
- IPN01195 for Advanced solid tumour
- Rabbit anti-human thymocyte immunoglobulin for Acute myeloid leukemia | Myelodysplastic syndrome | Chronic myeloid leukemia | Myeloproliferative disorder | MDS/MPD overlap | Acute lymphoblastic leukemia | Multiple myeloma | Chronic lymphocytic leukemia | Non-Hodgkin lymphoma | Hodgkin lymphoma